Author:
Panno M. L.,Giordano F.,Rizza P.,Pellegrino M.,Zito D.,Giordano C.,Mauro L.,Catalano S.,Aquila S.,Sisci D.,De Amicis F.,Vivacqua A.,Fuqua S. W. A.,Andò S.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Furr BJ, Jordan VC (1984) The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 2:127–205
2. Osborne CK, Coronado-Heinsohn EB, Hilsenbeck SG, Mc-Cue BL, Wakeling AE, McClelland RA, Manning DL, Nicholson RI (1995) Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. J Natl Cancer Inst 87:746–750
3. Johnston SR, Head J, Pancholi S, Detre S, Martin LA, Smith IE, Dowsett M (2003) Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancer. Clin Cancer Res 9(1 Pt 2):524S–532S
4. Morrow M, Jordan VC (1993) Molecular mechanisms of resistance to tamoxifen therapy in breast cancer. Arch Surg 128:1187–1191
5. Zhang Y, Moerkens M, Ramaiahgari S, de Bont H, Price L, Meerman J, van de Water B (2011) Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3 K/Akt signaling routes. Breast Cancer Res 3:R52
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献